A detailed history of Washington Trust CO transactions in Pfizer Inc stock. As of the latest transaction made, Washington Trust CO holds 329,946 shares of PFE stock, worth $9.06 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
329,946
Previous 334,411 1.34%
Holding current value
$9.06 Million
Previous $9.36 Million 2.05%
% of portfolio
0.34%
Previous 0.34%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$27.7 - $31.39 $123,680 - $140,156
-4,465 Reduced 1.34%
329,946 $9.55 Million
Q2 2024

Jul 15, 2024

SELL
$25.26 - $29.6 $233,200 - $273,267
-9,232 Reduced 2.69%
334,411 $9.36 Million
Q1 2024

Apr 23, 2024

SELL
$25.89 - $29.73 $77,566 - $89,071
-2,996 Reduced 0.86%
343,643 $9.54 Million
Q4 2023

Jan 18, 2024

SELL
$26.13 - $33.94 $81,003 - $105,214
-3,100 Reduced 0.89%
346,639 $9.98 Million
Q3 2023

Oct 18, 2023

BUY
$32.09 - $37.51 $77,144 - $90,174
2,404 Added 0.69%
349,739 $11.6 Million
Q2 2023

Jul 27, 2023

BUY
$36.12 - $41.79 $253,887 - $293,741
7,029 Added 2.07%
347,335 $12.7 Million
Q1 2023

May 10, 2023

BUY
$39.39 - $51.28 $13.4 Million - $17.4 Million
339,797 Added 99940.29%
340,137 $13.9 Million
Q1 2023

May 04, 2023

SELL
$39.39 - $51.28 $13.4 Million - $17.4 Million
-339,966 Reduced 99.9%
340 $13.9 Million
Q4 2022

Jul 27, 2023

BUY
$41.75 - $54.5 $7,055 - $9,210
169 Added 0.05%
340,306 $17.4 Million
Q4 2022

Feb 08, 2023

SELL
$41.75 - $54.5 $435,911 - $569,034
-10,441 Reduced 2.98%
340,306 $17.4 Million
Q3 2022

Oct 14, 2022

SELL
$43.76 - $53.42 $114,607 - $139,906
-2,619 Reduced 0.74%
350,747 $15.3 Million
Q2 2022

Jul 25, 2022

BUY
$46.53 - $55.17 $169,694 - $201,204
3,647 Added 1.04%
353,366 $18.5 Million
Q1 2022

May 05, 2022

SELL
$45.75 - $56.69 $118,858 - $147,280
-2,598 Reduced 0.74%
349,719 $18.1 Million
Q4 2021

Feb 09, 2022

SELL
$41.32 - $61.25 $1.75 Million - $2.6 Million
-42,388 Reduced 10.74%
352,317 $20.8 Million
Q3 2021

Nov 09, 2021

BUY
$39.25 - $50.42 $270,589 - $347,595
6,894 Added 1.78%
394,705 $17 Million
Q2 2021

Aug 05, 2021

BUY
$35.91 - $40.68 $402,227 - $455,656
11,201 Added 2.97%
387,811 $15.2 Million
Q1 2021

Apr 28, 2021

BUY
$33.49 - $37.77 $454,023 - $512,047
13,557 Added 3.73%
376,610 $13.6 Million
Q4 2020

Feb 09, 2021

BUY
$33.47 - $42.56 $264,714 - $336,607
7,909 Added 2.23%
363,053 $13.4 Million
Q3 2020

Nov 05, 2020

BUY
$31.75 - $37.25 $498,221 - $584,527
15,692 Added 4.62%
355,144 $13 Million
Q2 2020

Aug 04, 2020

SELL
$30.12 - $36.54 $750,951 - $911,015
-24,932 Reduced 6.84%
339,452 $11.1 Million
Q1 2020

May 07, 2020

BUY
$27.03 - $38.62 $494,162 - $706,050
18,282 Added 5.28%
364,384 $11.9 Million
Q4 2019

Feb 12, 2020

BUY
$32.92 - $37.36 $1.1 Million - $1.25 Million
33,558 Added 10.74%
346,102 $13.6 Million
Q3 2019

Nov 06, 2019

BUY
$32.49 - $42.13 $333,314 - $432,211
10,259 Added 3.39%
312,544 $12 Million
Q2 2019

Aug 07, 2019

BUY
$36.98 - $41.52 $209,565 - $235,293
5,667 Added 1.91%
302,285 $13.1 Million
Q1 2019

May 13, 2019

SELL
$37.5 - $41.2 $525,187 - $577,006
-14,005 Reduced 4.51%
296,618 $12.1 Million
Q4 2018

Feb 11, 2019

SELL
$38.47 - $43.86 $468,026 - $533,600
-12,166 Reduced 3.77%
310,623 $13.6 Million
Q3 2018

Nov 13, 2018

SELL
$34.47 - $41.81 $387,408 - $469,902
-11,239 Reduced 3.36%
322,789 $14.2 Million
Q2 2018

Aug 10, 2018

BUY
$32.98 - $35.16 $1.14 Million - $1.21 Million
34,508 Added 11.52%
334,028 $12.1 Million
Q1 2018

May 10, 2018

SELL
$31.91 - $37.02 $478,841 - $555,522
-15,006 Reduced 4.77%
299,520 $10.6 Million
Q4 2017

Feb 05, 2018

BUY
$33.26 - $35.29 $798 - $846
24 Added 0.01%
314,526 $11.4 Million
Q3 2017

Oct 31, 2017

BUY
$31.0 - $34.15 $9.75 Million - $10.7 Million
314,502
314,502 $11.2 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Washington Trust CO Portfolio

Follow Washington Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Washington Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Washington Trust CO with notifications on news.